{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:40:53Z","timestamp":1786120853242,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chemotherapy and targeted therapies, including anthracycline-based regimens or their combination, have significantly improved cancer patient survival; however, they are associated with cancer therapy\u2013related cardiac dysfunction (CTRCD), which may not be adequately detected using conventional two-dimensional echocardiography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To identify the available evidence on the application of three-dimensional echocardiography (3DE) in the evaluation of myocardial performance in patients undergoing anthracycline-based chemotherapy and\/or targeted therapy using cancer patients as a cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This scoping review was performed based on the Joanna Briggs Institute (JBI) framework of conducting scoping reviews and was reported in following the Preferred Reporting Items of systematic reviews and meta-analyses extension to Scoping Reviews (PRISMA-ScR). It searched five electronic databases (MEDLINE through PubMed, Embase, Scopus, Web of Science and Cochrane Library) dating back to November 2025. Records were independently screened and data extracted by two reviewers, any disagreement in this process was resolved by discussing with one another and when required, consulting with a third reviewer. A synthesis of 5 eligible observational studies was done using a narrative approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The studies that were included involved mostly breast cancer patients who were using anthracycline-based chemotherapy as a single agent or together with the use of HER2-targeted therapy. One of the studies assessed patients with chronic myeloid leukaemia receiving long term tyrosine kinase inhibitor (TKI) therapy whose treatment had not been exposed to anthracyclines. 3D measurements were taken to evaluate the baseline and follow-up assessment. Three-dimensional strain metrics, of which global longitudinal strain (GLS), global circumferential strain (GCS), and global area strain (GAS) were reported to identify features suggestive of subclinical myocardial dysfunction prior to observable reductions in left ventricular ejection fraction (LVEF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Available evidence indicates that 3DE, especially the three-dimensional myocardial strain analysis, may facilitate the earlier identification of subclinical myocardial dysfunction earlier in patients undergoing anthracycline-based chemotherapy and\/or targeted therapy. Nevertheless, due to the limited number of included studies and heterogeneity in its methods, these results are to be viewed with reservations and larger standardized multicenter studies are justified.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-05891-w","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:54:32Z","timestamp":1778921672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of myocardial performance using three-dimensional echocardiography in cancer patients exposed to anthracycline-based chemotherapy and\/or targeted therapy \u2013 a scoping review"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7605-1600","authenticated-orcid":false,"given":"Ananya P","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8099-7423","authenticated-orcid":false,"given":"Krishnananda","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-3972","authenticated-orcid":false,"given":"Karthik S","family":"Udupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3520-4420","authenticated-orcid":false,"given":"Ananth","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2003-426X","authenticated-orcid":false,"given":"Sharada","family":"Mailankody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-4630","authenticated-orcid":false,"given":"Kanhai Rajendra","family":"Lalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"19","key":"5891_CR1","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/cancers17193225","volume":"17","author":"S Saha","year":"2025","unstructured":"Saha S, Singh PK, Roy P, et al. Cancer-induced cardiac dysfunction: mechanisms, diagnostics, and emerging therapeutics in the era of onco-cardiology. Cancers. 2025;17(19):3225.","journal-title":"Cancers"},{"issue":"6","key":"5891_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.echo.2022.01.018","volume":"35","author":"Y Shen","year":"2022","unstructured":"Shen Y, Zhang H, Zhang Q, et al. Right ventricular ejection fraction assessed by three-dimensional echocardiography is associated with long-term adverse clinical cardiac events in patients with anthracycline-induced cardiotoxicity. J Am Soc Echocardiogr. 2022;35(6):600\u20138.","journal-title":"J Am Soc Echocardiogr"},{"key":"5891_CR3","doi-asserted-by":"publisher","first-page":"1406247","DOI":"10.3389\/fphar.2024.1406247","volume":"15","author":"S Xie","year":"2024","unstructured":"Xie S, Sun Y, Zhao X, et al. An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity. Front Pharmacol. 2024;15:1406247.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5891_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","volume":"8","author":"S Shyam Sunder","year":"2023","unstructured":"Shyam Sunder S, Sharma UC, Pokharel S. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Signal Transduct Target Therapy. 2023;8(1):262.","journal-title":"Signal Transduct Target Therapy"},{"issue":"4","key":"5891_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11912-022-01215-1","volume":"24","author":"KR Chitturi","year":"2022","unstructured":"Chitturi KR, Burns EA, Muhsen IN, et al. Cardiovascular risks with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and monoclonal antibody therapy. Curr Oncol Rep. 2022;24(4):475\u201391.","journal-title":"Curr Oncol Rep"},{"key":"5891_CR6","first-page":"100070","volume":"5","author":"I Osoro","year":"2022","unstructured":"Osoro I, Sharma A, Amir M, et al. Prevention and management of anthracycline induced cardiotoxicity: A review. Health Sci Rev. 2022;5:100070.","journal-title":"Health Sci Rev"},{"key":"5891_CR7","doi-asserted-by":"publisher","unstructured":"Sharma R, Kashyap J, Olanrewaju OA et al. Cardio-oncology: Managing cardiovascular complications of cancer therapies. Cureus. 2023;15(12):e51038. https:\/\/doi.org\/10.7759\/cureus.51038.","DOI":"10.7759\/cureus.51038"},{"issue":"1","key":"5891_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40959-023-00169-y","volume":"9","author":"WS El-Sherbeny","year":"2023","unstructured":"El-Sherbeny WS, Sabry NM, El-Saied SB, Elnagar B. Detection of right ventricular dysfunction by three-dimensional echocardiography and two-dimensional speckle tracking in breast cancer patients receiving anthracycline-based chemotherapy. Cardio-Oncology. 2023;9(1):20.","journal-title":"Cardio-Oncology"},{"issue":"15","key":"5891_CR9","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.3390\/diagnostics13152470","volume":"13","author":"AA Molnar","year":"2023","unstructured":"Molnar AA, Santa A, Merkely B. Echocardiography imaging of the right ventricle: focus on three-dimensional echocardiography. Diagnostics. 2023;13(15):2470.","journal-title":"Diagnostics"},{"issue":"5","key":"5891_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/diagnostics13050839","volume":"13","author":"M Keller","year":"2023","unstructured":"Keller M, Magunia H, Rosenberger P, Koeppen M. Echocardiography as a tool to assess cardiac function in critical care\u2014a review. Diagnostics. 2023;13(5):839.","journal-title":"Diagnostics"},{"issue":"1","key":"5891_CR11","doi-asserted-by":"publisher","first-page":"e15753","DOI":"10.1111\/echo.15753","volume":"41","author":"E Gherbesi","year":"2024","unstructured":"Gherbesi E, Gianstefani S, Angeli F, et al. Myocardial strain of the left ventricle by speckle tracking echocardiography: From physics to clinical practice. Echocardiography. 2024;41(1):e15753.","journal-title":"Echocardiography"},{"issue":"21","key":"5891_CR12","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.3390\/jcm11216307","volume":"11","author":"L Gao","year":"2022","unstructured":"Gao L, Lin Y, Ji M, et al. Clinical utility of three-dimensional speckle-tracking echocardiography in heart failure. J Clin Med. 2022;11(21):6307.","journal-title":"J Clin Med"},{"issue":"3","key":"5891_CR13","first-page":"340","volume":"18","author":"OA Smiseth","year":"2025","unstructured":"Smiseth OA, Rider O, Cvijic M, et al. Myocardial strain imaging: theory, current practice, and the future. Cardiovasc Imaging. 2025;18(3):340\u201381.","journal-title":"Cardiovasc Imaging"},{"key":"5891_CR14","doi-asserted-by":"publisher","first-page":"1236966","DOI":"10.3389\/fcvm.2024.1236966","volume":"11","author":"S Wang","year":"2024","unstructured":"Wang S, Wang Y, Wang S. The role of stress echocardiography in identifying cardiotoxicity: an in-depth exploration. Front Cardiovasc Med. 2024;11:1236966.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"5891_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ejhf.3167","volume":"26","author":"M Minamisawa","year":"2024","unstructured":"Minamisawa M, Inciardi RM, Claggett B, et al. Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON-HF study. Eur J Heart Fail. 2024;26(4):871\u201381.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"5891_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","volume":"27","author":"JC Plana","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27(9):911\u201339.","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"5891_CR17","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3390\/life13102103","volume":"13","author":"C Contaldi","year":"2023","unstructured":"Contaldi C, Montesarchio V, Catapano D, et al. Multimodality cardiovascular imaging of cardiotoxicity due to cancer therapy. Life. 2023;13(10):2103.","journal-title":"Life"},{"issue":"5","key":"5891_CR18","first-page":"655","volume":"6","author":"M Camilli","year":"2024","unstructured":"Camilli M, Cipolla CM, Dent S, Minotti G, Cardinale DM. Anthracycline cardiotoxicity in adult cancer patients: JACC: CardioOncology state-of-the-art review. Cardio Oncol. 2024;6(5):655\u201377.","journal-title":"Cardio Oncol"},{"issue":"41","key":"5891_CR19","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361.","journal-title":"Eur Heart J"},{"issue":"25 Pt A","key":"5891_CR20","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25 Pt A):2751\u201368.","journal-title":"J Am Coll Cardiol"},{"key":"5891_CR21","doi-asserted-by":"crossref","unstructured":"Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: Scoping Reviews. In: Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. JBI; 2024. Available from: https:\/\/synthesismanual.jbi.global","DOI":"10.46658\/JBIMES-24-09"},{"issue":"7","key":"5891_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"5891_CR23","doi-asserted-by":"publisher","first-page":"770580","DOI":"10.3389\/fphar.2021.770580","volume":"12","author":"J Guan","year":"2021","unstructured":"Guan J, Bao W, Xu Y, et al. Assessment of myocardial work in cancer therapy-related cardiac dysfunction and analysis of CTRCD prediction by echocardiography. Front Pharmacol. 2021;12:770580.","journal-title":"Front Pharmacol"},{"issue":"8","key":"5891_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/ehjci\/jex033","volume":"18","author":"C Santoro","year":"2017","unstructured":"Santoro C, Arpino G, Esposito R, et al. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility. Eur Heart J Cardiovasc Imaging. 2017;18(8):930\u20137.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"5891_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00392-019-01556-1","volume":"109","author":"M Coutinho Cruz","year":"2020","unstructured":"Coutinho Cruz M, Moura Branco L, Portugal G, et al. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines. Clin Res Cardiol. 2020;109(5):678\u201390.","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"5891_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/heartjnl-2019-316297","volume":"106","author":"J Lambert","year":"2020","unstructured":"Lambert J, Lamacie M, Thampinathan B, et al. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity. Heart. 2020;106(11):817\u201323.","journal-title":"Heart"},{"issue":"3","key":"5891_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamacardio.2021.5881","volume":"7","author":"M Esmaeilzadeh","year":"2022","unstructured":"Esmaeilzadeh M, Urzua Fresno CM, Somerset E, et al. A combined echocardiography approach for the diagnosis of cancer therapy-related cardiac dysfunction in women with early-stage breast cancer. JAMA Cardiol. 2022;7(3):330\u201340.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"5891_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s12012-020-09613-2","volume":"21","author":"UN Karakulak","year":"2021","unstructured":"Karakulak UN, Aladag E, Hekimsoy V, et al. Four-dimensional echocardiographic evaluation of left ventricular systolic functions in patients with chronic myeloid leukaemia receiving tyrosine kinase inhibitors. Cardiovasc Toxicol. 2021;21(1):100\u201311.","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"5891_CR29","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1186\/s12885-018-4935-z","volume":"18","author":"MC Arciniegas Calle","year":"2018","unstructured":"Arciniegas Calle MC, Sandhu NP, Asad MF, et al. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. BMC Cancer. 2018;18(1):1037.","journal-title":"BMC Cancer"},{"issue":"3","key":"5891_CR30","first-page":"312","volume":"84","author":"M Alam","year":"2024","unstructured":"Alam M, Takeuchi M, Nakatani S, et al. Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer. J Cardiol. 2024;84(3):312\u20139.","journal-title":"J Cardiol"},{"key":"5891_CR31","doi-asserted-by":"publisher","first-page":"842532","DOI":"10.3389\/fcvm.2022.842532","volume":"9","author":"R Piveta","year":"2022","unstructured":"Piveta R, Rodrigues ACT, Vieira MLC, et al. Early change in global longitudinal strain detected by 3D speckle tracking is associated with subsequent cardiotoxicity in patients treated with low doses of anthracyclines. Front Cardiovasc Med. 2022;9:842532.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"5891_CR32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s43046-020-00035-3","volume":"32","author":"WS El-Sherbeny","year":"2020","unstructured":"El-Sherbeny WS, El-Sayed MF, Shazly M. Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy. J Egypt Natl Canc Inst. 2020;32(1):22.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"2","key":"5891_CR33","first-page":"242","volume":"38","author":"B Wang","year":"2021","unstructured":"Wang B, Yu Y, Zhang Y, et al. Right ventricular dysfunction in patients with diffuse large B-cell lymphoma undergoing anthracycline-based chemotherapy: a 2D strain and 3D echocardiography study. Echocardiography. 2021;38(2):242\u201350.","journal-title":"Echocardiography"},{"issue":"7","key":"5891_CR34","first-page":"735","volume":"35","author":"Y Shen","year":"2022","unstructured":"Shen Y, Zhang H, Zhang Q, et al. Right ventricular ejection fraction assessed by three-dimensional echocardiography is associated with long-term adverse clinical cardiac events in patients with anthracycline-induced cardiotoxicity. J Am Soc Echocardiogr. 2022;35(7):735\u201345.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"5891_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaccao.2020.01.007","volume":"2","author":"R Zhao","year":"2020","unstructured":"Zhao R, Shu F, Zhang C, et al. Early detection and prediction of anthracycline-induced right ventricular cardiotoxicity by 3-dimensional echocardiography. JACC CardioOncol. 2020;2(1):13\u201322.","journal-title":"JACC CardioOncol"},{"issue":"1","key":"5891_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41392-023-01521-5","volume":"8","author":"L Tang","year":"2023","unstructured":"Tang L, Huang Z, Mei H, Hu Y. Immunotherapy in hematologic malignancies: achievements, challenges and future prospects. Signal Transduct Target Therapy. 2023;8(1):306.","journal-title":"Signal Transduct Target Therapy"},{"issue":"10","key":"5891_CR37","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.3390\/cancers15102858","volume":"15","author":"B Li","year":"2023","unstructured":"Li B, Jin J, Guo D, Tao Z, Hu X. Immune checkpoint inhibitors combined with targeted therapy: the recent advances and future potentials. Cancers. 2023;15(10):2858.","journal-title":"Cancers"},{"issue":"3","key":"5891_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","volume":"104","author":"WM Bramer","year":"2016","unstructured":"Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104(3):240\u20133.","journal-title":"J Med Libr Assoc"},{"key":"5891_CR39","doi-asserted-by":"publisher","unstructured":"Mihalcea D, Florescu M, Bruja R, Patrascu N, Vladareanu AM, Vinereanu D. 3D echocardiography, arterial stiffness, and biomarkers in early diagnosis and prediction of CHOP-induced cardiotoxicity in non-Hodgkin\u2019s lymphoma. Sci Rep. 2020;10:18473. https:\/\/doi.org\/10.1038\/s41598-020-75043-3.","DOI":"10.1038\/s41598-020-75043-3"},{"key":"5891_CR40","unstructured":"Lu S, Sun Y, Li Q, Liu Y, Cui H, Liang X. Three-dimensional speckle-tracking echocardiography to evaluate left ventricular function of patients with breast cancer after anthracycline chemotherapy. Altern Ther Health Med. 2023;29(7):388\u2013393."},{"key":"5891_CR41","doi-asserted-by":"publisher","unstructured":"Shi J, Guo Y, Cheng L, Song F, Shu X. Early change in left atrial function in patients treated with anthracyclines assessed by real-time three-dimensional echocardiography. Sci Rep. 2016;6:25512. https:\/\/doi.org\/10.1038\/srep25512.","DOI":"10.1038\/srep25512"},{"key":"5891_CR42","doi-asserted-by":"publisher","unstructured":"Karakulak UN, Aladag E, Hekimsoy V, Sahiner ML, Kaya EB, Ozer N, et al. Four-dimensional echocardiographic evaluation of left ventricular systolic functions in patients with chronic myeloid leukaemia receiving tyrosine kinase inhibitors. Cardiovasc Toxicol. 2021;21(3). https:\/\/doi.org\/10.1007\/s12012-020-09613-2.","DOI":"10.1007\/s12012-020-09613-2"},{"key":"5891_CR43","doi-asserted-by":"publisher","unstructured":"Chen J, Wang J, Tan L. Highly selective separation and detection of cyromazine from seawater using graphene oxide-based molecularly imprinted solid-phase extraction. J Sep Sci. 2019;42(12):2100\u201306. https:\/\/doi.org\/10.1002\/jssc.201900232.","DOI":"10.1002\/jssc.201900232"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05891-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T01:10:20Z","timestamp":1786065020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05891-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5891"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05891-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required, as this study is a scoping review of previously published literature.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"673"}}